Tempus AI, Inc. (NASDAQ:TEM) CEO Eric P. Lefkofsky Sells 74,485 Shares

Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) CEO Eric P. Lefkofsky sold 74,485 shares of the company's stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $67.53, for a total value of $5,029,972.05. Following the sale, the chief executive officer now owns 5,458,502 shares of the company's stock, valued at $368,612,640.06. This represents a 1.35 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Tempus AI Price Performance

TEM traded down $1.11 on Monday, reaching $67.85. The company's stock had a trading volume of 13,615,958 shares, compared to its average volume of 11,833,515. Tempus AI, Inc. has a 1 year low of $22.89 and a 1 year high of $79.49. The company has a current ratio of 2.69, a quick ratio of 2.55 and a debt-to-equity ratio of 8.17. The business's 50 day moving average is $44.49 and its 200 day moving average is $49.16.

Analyst Upgrades and Downgrades

TEM has been the subject of several analyst reports. TD Cowen reaffirmed a "buy" rating and issued a $74.00 target price (up previously from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Loop Capital decreased their target price on Tempus AI from $57.00 to $52.00 and set a "buy" rating for the company in a research report on Tuesday, January 14th. Piper Sandler reaffirmed a "neutral" rating and issued a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Guggenheim initiated coverage on Tempus AI in a research report on Monday, December 9th. They issued a "buy" rating and a $74.00 target price for the company. Finally, Stifel Nicolaus downgraded Tempus AI from a "buy" rating to a "hold" rating and upped their target price for the stock from $45.00 to $65.00 in a research report on Monday, November 11th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $58.55.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of the company. ARK Investment Management LLC lifted its holdings in Tempus AI by 132.1% during the 4th quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company's stock worth $186,343,000 after buying an additional 3,141,487 shares during the last quarter. NEA Management Company LLC lifted its holdings in Tempus AI by 17.8% during the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company's stock worth $304,846,000 after buying an additional 813,169 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. lifted its holdings in Tempus AI by 166.0% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after buying an additional 2,021,394 shares during the last quarter. Franklin Resources Inc. raised its position in shares of Tempus AI by 1.0% during the 3rd quarter. Franklin Resources Inc. now owns 811,311 shares of the company's stock worth $45,920,000 after purchasing an additional 8,387 shares during the period. Finally, Millennium Management LLC acquired a new stake in shares of Tempus AI during the 2nd quarter worth approximately $8,067,000. Institutional investors own 24.22% of the company's stock.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.